Edwards Lifesciences Quarterly Income Statements Chart
Quarterly
|
Annual
Edwards Lifesciences Quarterly Income Statements Table
Quarterly
|
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2007-06-30 | 2007-03-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-09-30 | 2005-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| net sales | 1,532,200,000 | 1,412,700,000 | 1,385,800,000 | 1,354,400,000 | 1,385,900,000 | 1,598,200,000 | 1,534,100,000 | 1,480,900,000 | 1,530,200,000 | 1,459,600,000 | 1,348,300,000 | 1,319,000,000 | 1,373,900,000 | 1,341,200,000 | 1,329,700,000 | 1,310,200,000 | 1,376,000,000 | 1,216,600,000 | 1,191,700,000 | 1,140,900,000 | 925,000,000 | 1,128,700,000 | 1,174,100,000 | 1,094,000,000 | 1,086,900,000 | 993,000,000 | 977,700,000 | 906,600,000 | 943,700,000 | 894,800,000 | 888,500,000 | 821,500,000 | 841,800,000 | 883,500,000 | 767,700,000 | 739,400,000 | 759,300,000 | 697,300,000 | 671,100,000 | 615,500,000 | 616,800,000 | 590,300,000 | 272,600,000 | 264,100,000 | 247,400,000 | 267,300,000 | 256,700,000 | 240.9 | 258,200,000 |
| cost of sales | 344,400,000 | 301,600,000 | 292,200,000 | 262,900,000 | 285,300,000 | 385,600,000 | 356,900,000 | 350,400,000 | 343,000,000 | 329,500,000 | 257,900,000 | 253,800,000 | 269,400,000 | 299,300,000 | 309,500,000 | 311,700,000 | 334,300,000 | 293,400,000 | 296,300,000 | 281,000,000 | 238,200,000 | 265,100,000 | 286,200,000 | 292,400,000 | 304,000,000 | 231,800,000 | 234,700,000 | 224,900,000 | 246,200,000 | 233,600,000 | 235,300,000 | 213,300,000 | 211,100,000 | 215,600,000 | 213,200,000 | 201,400,000 | 202,500,000 | 180,300,000 | 175,900,000 | 146,700,000 | 158,600,000 | 136,000,000 | |||||||
| gross profit | 1,187,800,000 | 1,111,100,000 | 1,093,600,000 | 1,091,500,000 | 1,100,600,000 | 1,212,600,000 | 1,177,200,000 | 1,130,500,000 | 1,187,200,000 | 1,130,100,000 | 1,090,400,000 | 1,065,200,000 | 1,104,500,000 | 1,041,900,000 | 1,020,200,000 | 998,500,000 | 1,041,700,000 | 923,200,000 | 895,400,000 | 859,900,000 | 686,800,000 | 863,600,000 | 887,900,000 | 801,600,000 | 782,900,000 | 761,200,000 | 743,000,000 | 681,700,000 | 697,500,000 | 661,200,000 | 653,200,000 | 608,200,000 | 630,700,000 | 667,900,000 | 554,500,000 | 538,000,000 | 556,800,000 | 517,000,000 | 495,200,000 | 468,800,000 | 458,200,000 | 454,300,000 | 177,900,000 | 170,900,000 | 160,000,000 | 171,600,000 | 163,600,000 | 150 | 160,300,000 |
| yoy | 7.92% | -8.37% | -7.10% | -3.45% | -7.29% | 7.30% | 7.96% | 6.13% | 7.49% | 8.47% | 6.88% | 6.68% | 6.03% | 12.86% | 13.94% | 16.12% | 51.67% | 6.90% | 0.84% | 7.27% | -12.27% | 13.45% | 19.50% | 17.59% | 12.24% | 15.12% | 13.75% | 12.08% | 10.59% | -1.00% | 17.80% | 13.05% | 13.27% | 29.19% | 11.97% | 14.76% | 21.52% | 13.80% | 178.36% | 174.31% | 186.38% | 164.74% | 8.74% | 113933233.33% | -0.19% | ||||
| qoq | 6.90% | 1.60% | 0.19% | -0.83% | -9.24% | 3.01% | 4.13% | -4.78% | 5.05% | 3.64% | 2.37% | -3.56% | 6.01% | 2.13% | 2.17% | -4.15% | 12.84% | 3.10% | 4.13% | 25.20% | -20.47% | -2.74% | 10.77% | 2.39% | 2.85% | 2.45% | 8.99% | -2.27% | 5.49% | 1.22% | 7.40% | -3.57% | -5.57% | 20.45% | 3.07% | -3.38% | 7.70% | 4.40% | 5.63% | 2.31% | 0.86% | 155.37% | 4.10% | 6.81% | -6.76% | 4.89% | 109066566.67% | -100.00% | |
| gross margin % | |||||||||||||||||||||||||||||||||||||||||||||||||
| selling, general, and administrative expenses | 502,000,000 | 465,700,000 | 491,900,000 | 421,400,000 | 450,800,000 | 489,700,000 | 480,000,000 | 439,600,000 | 468,700,000 | 436,300,000 | 411,000,000 | 377,300,000 | 409,000,000 | 370,300,000 | 424,000,000 | 364,400,000 | 374,500,000 | 330,800,000 | 338,500,000 | 307,200,000 | 274,900,000 | 307,800,000 | 347,200,000 | 306,200,000 | 308,500,000 | 280,300,000 | 288,100,000 | 269,500,000 | 274,900,000 | 256,000,000 | 266,700,000 | 244,600,000 | 243,800,000 | 229,600,000 | 233,600,000 | 229,600,000 | 228,800,000 | 212,700,000 | 222,300,000 | 212,000,000 | 213,900,000 | 202,500,000 | |||||||
| research and development expenses | 276,200,000 | 254,600,000 | 271,100,000 | 253,400,000 | 272,600,000 | 285,200,000 | 270,000,000 | 270,300,000 | 270,300,000 | 261,200,000 | 232,200,000 | 233,600,000 | 250,800,000 | 228,600,000 | 232,800,000 | 238,000,000 | 225,300,000 | 207,000,000 | 195,700,000 | 195,500,000 | 182,100,000 | 187,400,000 | 193,900,000 | 195,500,000 | 191,900,000 | 171,400,000 | 163,100,000 | 161,800,000 | 154,100,000 | 143,200,000 | 146,600,000 | 142,900,000 | 134,400,000 | 128,700,000 | 114,900,000 | 113,100,000 | 112,900,000 | 102,400,000 | 98,200,000 | 101,000,000 | 97,500,000 | 86,400,000 | 29,100,000 | 28,800,000 | 28,100,000 | 28,900,000 | 27,200,000 | 24 | 24,200,000 |
| certain litigation expenses | 15,500,000 | 10,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| separation costs | 4,200,000 | 4,200,000 | 41,300,000 | ||||||||||||||||||||||||||||||||||||||||||||||
| other operating income | -21,300,000 | -19,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| operating income | 411,200,000 | 394,800,000 | 312,600,000 | 350,600,000 | 369,100,000 | 387,500,000 | 400,100,000 | 418,400,000 | 327,200,000 | 388,400,000 | 447,800,000 | 402,400,000 | 459,500,000 | 438,800,000 | 374,400,000 | 390,300,000 | 542,100,000 | 383,500,000 | 351,400,000 | 357,800,000 | -169,700,000 | 358,100,000 | 310,800,000 | 294,300,000 | 267,500,000 | 274,200,000 | -5,300,000 | 248,900,000 | 252,100,000 | 252,500,000 | |||||||||||||||||||
| yoy | 11.41% | 1.88% | -21.87% | -16.20% | 12.81% | -0.23% | -10.65% | 3.98% | -28.79% | -11.49% | 19.60% | 3.10% | -15.24% | 14.42% | 6.55% | 9.08% | -419.45% | 7.09% | 13.06% | 21.58% | -163.44% | 30.60% | -5964.15% | 18.24% | 6.11% | 8.59% | |||||||||||||||||||||||
| qoq | 4.15% | 26.30% | -10.84% | -5.01% | -4.75% | -3.15% | -4.37% | 27.87% | -15.76% | -13.26% | 11.28% | -12.43% | 4.72% | 17.20% | -4.07% | -28.00% | 41.36% | 9.13% | -1.79% | -310.84% | -147.39% | 15.22% | 5.61% | 10.02% | -2.44% | -5273.58% | -102.13% | -1.27% | -0.16% | ||||||||||||||||||||
| operating margin % | |||||||||||||||||||||||||||||||||||||||||||||||||
| interest income | -37,400,000 | -36,500,000 | -64,000,000 | -24,300,000 | -15,500,000 | -16,500,000 | -34,400,000 | -15,100,000 | -9,100,000 | -8,600,000 | -27,100,000 | -6,900,000 | -900,000 | -600,000 | -18,900,000 | 800,000 | 1,000,000 | -300,000 | -16,300,000 | -800,000 | -1,800,000 | -4,500,000 | -25,000,000 | -2,800,000 | -2,400,000 | -2,000,000 | -31,700,000 | 500,000 | -800,000 | ||||||||||||||||||||
| loss on impairment | 47,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| other non-operating income | 1,300,000 | -2,600,000 | -33,300,000 | -27,900,000 | |||||||||||||||||||||||||||||||||||||||||||||
| income from continuing operations before benefit from income taxes | 400,200,000 | 433,900,000 | 390,100,000 | 402,800,000 | 386,600,000 | ||||||||||||||||||||||||||||||||||||||||||||
| benefit from income taxes | 64,300,000 | 70,300,000 | 45,100,000 | 40,700,000 | 20,200,000 | 58,400,000 | 52,000,000 | 55,600,000 | 33,000,000 | 58,100,000 | 60,900,000 | 63,800,000 | 58,300,000 | 62,500,000 | 41,000,000 | 50,800,000 | 56,000,000 | 51,100,000 | 46,600,000 | 39,100,000 | 53,900,000 | 35,300,000 | 27,000,000 | 29,000,000 | 28,300,000 | -8,800,000 | 22,800,000 | 56,900,000 | 326,700,000 | 41,700,000 | 19,500,000 | 63,400,000 | 41,900,000 | 43,800,000 | 42,400,000 | 40,300,000 | 26,300,000 | 32,600,000 | 29,500,000 | 39,100,000 | 11,900,000 | 11,400,000 | 8,900,000 | 9,400,000 | 20,500,000 | 19.7 | 1,400,000 | ||
| net income from continuing operations | 335,900,000 | 363,600,000 | 345,000,000 | 362,100,000 | 366,400,000 | ||||||||||||||||||||||||||||||||||||||||||||
| income from discontinued operations, net of tax | -4,400,000 | -7,200,000 | 39,300,000 | 2,707,300,000 | -1,400,000 | ||||||||||||||||||||||||||||||||||||||||||||
| net income | 331,500,000 | 356,400,000 | 384,300,000 | 3,069,400,000 | 365,000,000 | 351,000,000 | 369,700,000 | 383,700,000 | 305,500,000 | 340,500,000 | 398,400,000 | 343,500,000 | 406,400,000 | 373,600,000 | 335,300,000 | 340,100,000 | 489,500,000 | 338,200,000 | 309,500,000 | 325,200,000 | -121,900,000 | 310,600,000 | 280,200,000 | 274,700,000 | 242,300,000 | 249,700,000 | 7,000,000 | 225,900,000 | 282,700,000 | 206,600,000 | -2,800,000 | 170,100,000 | 186,100,000 | 230,200,000 | 158,500,000 | 141,400,000 | 126,600,000 | 143,000,000 | 140,700,000 | 118,100,000 | 112,700,000 | 123,400,000 | 34,900,000 | 33,200,000 | 27,800,000 | 36,100,000 | 45,900,000 | -4.4 | 13,900,000 |
| yoy | -9.18% | 1.54% | 3.95% | 699.95% | 19.48% | 3.08% | -7.20% | 11.70% | -24.83% | -8.86% | 18.82% | 1.00% | -16.98% | 10.47% | 8.34% | 4.58% | -501.56% | 8.89% | 10.46% | 18.38% | -150.31% | 24.39% | 3902.86% | 21.60% | -14.29% | 20.86% | -350.00% | 32.80% | 51.91% | -10.25% | -101.77% | 20.30% | 47.00% | 60.98% | 12.65% | 19.73% | 12.33% | 15.88% | 303.15% | 255.72% | 305.40% | 241.83% | -23.97% | -754545554.55% | 100.00% | ||||
| qoq | -6.99% | -7.26% | -87.48% | 740.93% | 3.99% | -5.06% | -3.65% | 25.60% | -10.28% | -14.53% | 15.98% | -15.48% | 8.78% | 11.42% | -1.41% | -30.52% | 44.74% | 9.27% | -4.83% | -366.78% | -139.25% | 10.85% | 2.00% | 13.37% | -2.96% | 3467.14% | -96.90% | -20.09% | 36.83% | -7478.57% | -101.65% | -8.60% | -19.16% | 45.24% | 12.09% | 11.69% | -11.47% | 1.63% | 19.14% | 4.79% | -8.67% | 253.58% | 5.12% | 19.42% | -22.99% | -21.35% | -1043181918.18% | -100.00% | |
| net income margin % | |||||||||||||||||||||||||||||||||||||||||||||||||
| net income attributable to noncontrolling interest | -1,700,000 | -1,600,000 | -1,300,000 | -1,400,000 | -1,300,000 | -900,000 | -200,000 | -1,200,000 | -1,600,000 | ||||||||||||||||||||||||||||||||||||||||
| net income attributable to edwards lifesciences corporation | 333,200,000 | 358,000,000 | 947,250,000 | 3,070,800,000 | 366,300,000 | 351,900,000 | 258,125,000 | 384,900,000 | 307,100,000 | ||||||||||||||||||||||||||||||||||||||||
| share information | |||||||||||||||||||||||||||||||||||||||||||||||||
| earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 0.58 | 0.61 | 0.63 | 0.51 | 0.56 | 0.65 | 0.55 | 0.65 | 0.6 | 0.54 | 0.55 | 0.79 | 0.54 | 0.49 | 0.52 | -0.2 | 1.49 | 1.35 | 1.32 | 1.16 | 1.2 | 0.04 | 1.08 | 1.35 | 0.98 | -0.01 | 0.81 | 0.88 | 1.09 | 0.74 | 0.66 | 0.6 | 0.67 | -0.99 | 1.1 | 1.05 | 1.14 | 0.61 | 0.57 | 0.48 | 0.61 | 0.77 | -0.07 | 0.23 | |||||
| continuing operations | 0.58 | 0.62 | 0.58 | 0.61 | 0.61 | ||||||||||||||||||||||||||||||||||||||||||||
| discontinued operations | -0.01 | -0.01 | 0.09 | 4.53 | |||||||||||||||||||||||||||||||||||||||||||||
| basic earnings per share | 0.57 | 0.61 | 0.67 | 5.14 | 0.61 | ||||||||||||||||||||||||||||||||||||||||||||
| diluted | |||||||||||||||||||||||||||||||||||||||||||||||||
| diluted earnings per share | 0.56 | 0.61 | 0.68 | 5.13 | 0.61 | ||||||||||||||||||||||||||||||||||||||||||||
| weighted-average number of common shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 587 | 586.9 | 597.7 | 597.2 | 602.1 | 601.6 | 606.7 | 607 | 606.9 | 607.5 | 619 | 619.8 | 620.9 | 622.1 | 623.3 | 623.6 | 622.3 | 623.2 | 622.6 | 622.1 | 620.3 | 208.2 | 208.3 | 208.2 | 208.1 | 207.9 | 209.2 | 209 | 209.5 | 210.2 | 210.9 | 211.3 | 210.5 | 211.2 | 213 | 213.2 | 212.2 | 213.1 | 215.5 | 107.6 | 107.6 | 107.8 | 57.5 | 57.9 | 58.2 | 58.8 | 59.3 | 59.8 | 59.6 |
| diluted | 587.9 | 587.8 | 599.3 | 598.1 | 604.3 | 604.1 | 609.4 | 609.5 | 610.3 | 610.9 | 624.2 | 624.5 | 626.7 | 629.4 | 631.2 | 631.7 | 629.9 | 631.3 | 631.9 | 631 | 620.3 | 211.7 | 212.2 | 212.1 | 212.1 | 212.2 | 213.6 | 213.2 | 214 | 215.1 | 215.9 | 216.2 | 215.7 | 216.4 | 217.8 | 218.1 | 217.3 | 217.8 | 220.3 | 110 | 110 | 110.3 | 63 | 63.5 | 63.6 | 64.2 | 64.6 | 59.8 | 62.4 |
| intellectual property agreement and certain litigation expenses | 12,600,000 | 10,800,000 | 8,100,000 | 8,900,000 | |||||||||||||||||||||||||||||||||||||||||||||
| change in fair value of contingent consideration liabilities | -26,900,000 | 700,000 | 500,000 | -12,500,000 | -20,900,000 | -2,900,000 | -18,100,000 | 1,100,000 | -102,600,000 | -4,500,000 | 5,200,000 | -9,000,000 | 19,600,000 | -2,200,000 | -18,500,000 | -2,300,000 | 8,000,000 | 6,700,000 | -14,000,000 | -6,400,000 | 10,900,000 | 3,800,000 | 2,600,000 | -16,700,000 | 3,100,000 | 1,100,000 | |||||||||||||||||||||||
| restructuring expenses | 8,225,000 | 32,900,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| other operating expenses | 5,600,000 | 22,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| other income | -2,000,000 | -5,400,000 | -4,800,000 | -5,800,000 | -2,200,000 | -1,600,000 | -3,600,000 | 2,000,000 | -4,300,000 | 3,300,000 | -1,400,000 | -1,400,000 | -4,400,000 | -5,500,000 | -4,200,000 | -5,700,000 | 300,000 | -1,900,000 | -400,000 | -4,600,000 | -1,400,000 | -1,800,000 | -1,700,000 | -300,000 | 1,100,000 | -3,100,000 | 4,000,000 | 1,800,000 | 200,000 | 1,800,000 | 200,000 | 700,000 | 300,000 | 700,000 | |||||||||||||||
| income before benefit from income taxes | 409,400,000 | 421,700,000 | 439,300,000 | 338,500,000 | 398,600,000 | 459,300,000 | 407,300,000 | 464,700,000 | 436,100,000 | 376,300,000 | 390,900,000 | 545,500,000 | 389,300,000 | 356,100,000 | 364,300,000 | -168,200,000 | 364,500,000 | 315,500,000 | 301,700,000 | 271,300,000 | 278,000,000 | -1,800,000 | 248,700,000 | 251,000,000 | 263,500,000 | 323,900,000 | 211,800,000 | 205,600,000 | 293,600,000 | 200,400,000 | 185,200,000 | 169,000,000 | 183,300,000 | 167,000,000 | 150,700,000 | 142,200,000 | 162,500,000 | 46,800,000 | 44,600,000 | 36,700,000 | 45,500,000 | 66,400,000 | 15.3 | 15,300,000 | |||||
| earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||
| basic | 0.58 | 0.61 | 0.63 | 0.51 | 0.56 | 0.65 | 0.55 | 0.65 | 0.6 | 0.54 | 0.55 | 0.79 | 0.54 | 0.49 | 0.52 | -0.2 | 1.49 | 1.35 | 1.32 | 1.16 | 1.2 | 0.04 | 1.08 | 1.35 | 0.98 | -0.01 | 0.81 | 0.88 | 1.09 | 0.74 | 0.66 | 0.6 | 0.67 | -0.99 | 1.1 | 1.05 | 1.14 | 0.61 | 0.57 | 0.48 | 0.61 | 0.77 | -0.07 | 0.23 | |||||
| diluted | 0.58 | 0.61 | 0.63 | 0.5 | 0.56 | 0.65 | 0.55 | 0.65 | 0.59 | 0.53 | 0.54 | 0.78 | 0.54 | 0.48 | 0.52 | -0.2 | 1.47 | 1.32 | 1.3 | 1.14 | 1.18 | 0.04 | 1.06 | 1.32 | 0.96 | -0.01 | 0.79 | 0.86 | 1.06 | 0.72 | 0.65 | 0.58 | 0.66 | -0.97 | 1.07 | 1.02 | 1.12 | 0.57 | 0.54 | 0.45 | 0.58 | 0.73 | -0.07 | 0.22 | |||||
| intellectual property agreement and litigation income | 48,400,000 | 2,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| special charge | -6,100,000 | 66,800,000 | 6,000,000 | 24,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
| intellectual property agreement and litigation expense | 147,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| intellectual property agreement and litigation expenses | 43,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| intellectual property litigation incomes | 2,700,000 | -2,400,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| intellectual property litigation expenses | 6,100,000 | 7,100,000 | 7,100,000 | 4,700,000 | 2,400,000 | 6,400,000 | 4,600,000 | 8,400,000 | 379,900,000 | 12,500,000 | 13,900,000 | 7,900,000 | 7,000,000 | 4,600,000 | 194,900,000 | 7,900,000 | 5,500,000 | 5,700,000 | 7,900,000 | 13,700,000 | 7,700,000 | 10,200,000 | 4,800,000 | 6,500,000 | 9,100,000 | 12,200,000 | 3,300,000 | 2,400,000 | 300,000 | ||||||||||||||||||||
| (benefit from) benefit from income taxes | -46,300,000 | -31,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||
| special gain | |||||||||||||||||||||||||||||||||||||||||||||||||
| special charges | 18,500,000 | 10,200,000 | 31,200,000 | 34,500,000 | 2,000,000 | 21.4 | 27,600,000 | ||||||||||||||||||||||||||||||||||||||||||
| special gains | -7,100,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| interest expense | 19,300,000 | 100,000 | 1,400,000 | 2,400,000 | 12,300,000 | 2,100,000 | 2,400,000 | 2,400,000 | 10,500,000 | 2,500,000 | 1,800,000 | 2,400,000 | 400,000 | 200,000 | 800,000 | 600,000 | 900,000 | 2.2 | 3,300,000 | ||||||||||||||||||||||||||||||
| other incomes | 1,850,000 | 1,600,000 | 3,500,000 | 2,300,000 | 1,400,000 | 1,500,000 | 100,000 | ||||||||||||||||||||||||||||||||||||||||||
| intellectual property litigation expenses (income) | 1,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
| cost of goods sold | 94,700,000 | 93,200,000 | 87,400,000 | 95,700,000 | 93,100,000 | 90.9 | 97,900,000 | ||||||||||||||||||||||||||||||||||||||||||
| selling, general and administrative expenses | 101,700,000 | 98,600,000 | 91,700,000 | 97,000,000 | 92,200,000 | 85.9 | 90,100,000 | ||||||||||||||||||||||||||||||||||||||||||
| purchased in-process research and development expenses | 1.2 | ||||||||||||||||||||||||||||||||||||||||||||||||
| special | |||||||||||||||||||||||||||||||||||||||||||||||||
| special gains, net of charges | |||||||||||||||||||||||||||||||||||||||||||||||||
| share information: |
We provide you with 20 years income statements for Edwards Lifesciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Edwards Lifesciences stock. Explore the full financial landscape of Edwards Lifesciences stock with our expertly curated income statements.
The information provided in this report about Edwards Lifesciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.